Health TV:

Wednesday 30 November, 2022: Life Sciences and Biotech & Virtual meetings
Thursday 1 December, 2022: Digital Health, MedTech & Diagnostics & Virtual meetings
Friday 2 December, 2022: Additional time slots for virtual meetings

Thank you for attending the event and for your interest in the Finnish innovations! We hope that the discussions continue after the event.

A warm welcome to the third virtual investor event to meet the most prominent Finnish health and life science focused research groups! The event is invite-only and free-of-charge for international and Finnish investors.

During the online event, you will have an opportunity to:

• Listen to the pitches of the most prominent health and life science focused research groups of the Finnish universities
• Virtually meet with the research groups in 1-to-1 meetings after the pitches

The research groups are selected by Business Finland in cooperation with the Finnish universities, and you can find the details of the research groups below.

Register now, and you are all set to start booking 1-to-1 virtual meetings with the research groups.

The event is organised by:

The event is organized online and in two parts according to theme. You can choose to participate on both days, or just one.

Wednesday, 30 November:
Life Sciences and Biotech

13:00-13:10 EET/
11:00-11:10 GMT
Welcome words:
Sampo Sammalisto (host), Head of Personalized Health Finland, Business Finland

Research to Business Funding:
Outi Keski-Äijö, Ecosystem Lead, AI, Data & Quantum, Business Finland

13:10-15:15 EET/
11:10-13:15 GMT
Pitches by the research groups

15:30-20:00 EET/
13:30-18:00 GMT
Virtual 1-to-1 meetings

Thursday, 1 December:
Digital Health, MedTech & Diagnostics

13:00-13:10 EET /
11:00-11:10 GMT
Welcome words:
Tarja Enala (host), Senior Advisor, Health and Wellbeing, Invest in Finland at Business Finland

Reseach to Business Funding:
Jaana Rantanen, Senior Adviser, Business Finland

13:10-15:45 EET /
11:10-13:45 GMT
Pitches by the research groups

16:00-20:00 EET /
14:00-18:00 GMT
Virtual 1-to-1 meetings

Friday, 2 December:
Virtual meetings continue

09:00-15:00 EET /
07:00-13:00 GMT
Additional time slots for virtual 1-to-1 meetings

*Slight delays may occur during the event.Exact time slots are announced closer to the event.13:13 EET
11:13 GMTEPLINExEarly detection of aggressive cancer and novel biomarker-guided cancer treatment. The biggest challenge in hospitals treating patients with HNSCC (head and neck squamous cell carcinoma) is the lack of biomarkers that could be used in cancer treatment planning, disease progression monitoring, or in predicting treatment response. In our recent studies, we have been able to develop a very promising method (EPLINEx) to identify metastatic HNSCC cancer at an early stage.Presenter: Sami Ventelä
Contact: sami.ventela@utu.fi, matti juvonen@utu.fi
University: University of TurkuLife Sciences / Diagnostics13:21 EET
11:21 GMT3D-FLUOHISTO Novel 3D histology solutions for life science, pharma and biotech3D FLUOHISTO brings into use the latest technology to enable advanced approach for tissue analysis in the means of providing leading 3 D histology analysis services. It is our mission to provide life science, pharma, biotech and hospitals remarkably efficient and accurate solutions by leveraging 3 D histology.Presenter: Miika Niemeläinen
Contact: miika.niemelainen@utu.fi, ilkka.paatero@utu.fi
University: University of TurkuLife Sciences / Biotech13:30 EET
11:30 GMTIntegrated Secretion Solutions (ISS)Boosting therapeutic protein production.Presenter: Ville Paavilainen
Contact: ville.paavilainen@helsinki.fi, katja.rosti@helsinki.fi
University: University of HelsinkiLife Sciences / Biotech13:39 EET
11:39 GMTRevEyeFrom fundamental ocular surface research to the commercialization of a novel dry eye treatment.Presenter: Kari Lehmussaari
Contact: kari.lehmussaari@helsinki.fi, marika.ruponen@helsinki.fi, filip.ekholm@helsinki.fi
University: University of HelsinkiLife Sciences / Biotech13:48 EET
11:48 GMTGlobeVACA thermostable vaccine formulation for global immunisation.Presenter: Manlio Fusciello
Contact: manlio.fusciello@helsinki.fi, vincenzo.cerullo@helsinki.fi
University: University of HelsinkiLife Sciences / Biotech13:57-14:15 EET
11:57-12:15 GMTBREAK14:16 EET
12:16 GMTGlue4Life – Next generation bioinks for printing lifeOur bioink innovation, Glue4Life, is a next generation bioink for 3D bioprinting of living tissues and organs. We envision to advance the development of artificial tissues and organs for future clinical applications by offering bioinks manufactured with clinically compatible components.Presenter: Paula Puistola
Contact: paula.puistola@tuni.fi, anni.moro@tuni.fi
University: Tampere UniversityLife Sciences / Biotech14:25 EET
12:25 GMTMEMOMEMO project is devoted for the concept proof (verification and validation) studies on the novel enabling technology based on innovative brain-on-chip principle for the modeling of epileptic seizures, and striving for the commercialization of technology to global drug discovery markets.Presenter: Satu Jäntti
Contact: susanna.narkilahti@tuni.fi, satu.jantti@tuni.fi
University: Tampere UniversityLife Sciences / Biotech14:34 EET
12:34 GMTArivin TherapeuticsTo mitigate infectious diseases and antimicrobial resistance. A lead opportunity has been identified in developing a treatment for chronic Pseudomonas aeruginosa in Cystic Fibrosis.Presenter: Christopher Jonkergouw
Contact: christopher.jonkergouw@aalto.fi
University: Aalto UniversityLife Sciences / Biotech14:43 EET
12:43 GMTMoncyteMoncyte test sheds light on why some people respond differently to cholesterol-lowering drugs, opening new ways for personalized medicine and improving patient lives.Presenter: Simon Pfisterer
Contact: simon.pfisterer@helsinki.fi
University: University of HelsinkiDiagnostics14:52 EET
12:52 GMTImmunateImmunate develops microscopy technology with the goal of significantly enhancing the adoptability of 3D cell culture in research and industry.Presenter: Margita Engström
Contact: margita.engstrom@gmail.com, juho.pokki@aalto.fi
University: Aalto UniversityDiagnostics15:01 EET
13:01 GMTUrisensUrine parameters will be measured with printed sensors. They provide automated urine assessment for diagnostic support.Presenter: Oguz Tanzer
Contact: oguz.tanzer@aalto.fi
University: Aalto UniversityDiagnostics15:10 EET
13:10 GMTCLOSING WORDS & BREAK15:30 EET
13:30 GMTMATCHMAKING STARTSExact time slots are announced closer to the event.13:12 EET
11:12 GMTmTMSAI-utilizing multi-locus transcranial magnetic stimulation (TMS) technology that will enable new closed-loop, feed-back-controlled brain therapy. Huge therapeutic benefits may be obtained, saving the EU area even one billion euros from the annual costs of brain disorders.Presenter: Dubravko Kicic
Contact: dubravko.kicic@aalto.fi, thomas.lemstrom@aalto.fi, jaakko.nieminen@aalto.fi
University: Aalto UniversityMedTech / Diagnostics13:21 EET
11:21 GMTMEGMRIMEG-MRI scanner performs functional and structural imaging in a single study. Hybrid MEG-MRI Brain Scanner provides simpler workflow and up to 95% less error.Presenter: Marko Havu
Contact: marko.havu@aalto.fi, thomas.lemstrom@aalto.fi
University: Aalto UniversityDiagnostics13:30 EET
11:30 GMTDetecorDetection of corrosion from stainless steel medical instruments in hospitals.Presenter: Juho Lehmusto
Contact: juho.lehmusto@abo.fi, mikael.bergelin@abo.fi, leena.hupa@abo.fi
Research organisation: Åbo AkademiDiagnostics13:39 EET
11:39 GMTMoreStaminaAn evidence-based fatigue management solution for persons with Multiple Sclerosis.Presenter: Guido Giunti Garcia
Contact: guido.giunti@oulu.fi
University: University of OuluDigital Health13:48 EET
11:48 GMTGARMENTGARMENT creates a wearable-based platform that connects games to a healthier personalized gamified daily life. The youth is very hooked on screens and lives a sedentary lifestyle, causing medical and health issues in the long term. Our solution is merging games with the daily physical activity of players. Because gaming is a rapidly growing market, youth are looking for more realism and immersion, and parents and organizations look for health solutions. GARMENT offers to bridge daily physical activity and games by creating a platform where players can gain in-game awards based on their physical activity in everyday life.Presenter: Oğuz “Oz” Buruk
Contact: oguz.buruk@tuni.fi
University: Tampere UniversityDigital Health13:57 EET
11:57 GMTSoihtu DTxMedical gaming solution for treatment of depression.Presenter: Joonas Juvonen
Contact: joonas.j.juvonen@aalto.fi, jukka.t.laakso@aalto.fi, sami.k.lehtinen@aalto.fi, matias.palva@aalto.fi
University: Aalto UniversityDigital Health14:06 EET
12:06 GMTBioLiDARNext Generation Optical Sport Sensor for Wearable Devices.Presenter: Jan Nissinen
Contact: jan.nissinen@oulu.fi
University: University of OuluDigital Health / MedTech14:15 EET
12:15 GMTEmedpatchMulti-functional, self-sustainable sensing components for smart skin.Presenter: Yang Bai
Contact: yang.bai@oulu.fi
University: University of OuluDigital Health / MedTech14:25-14:35 EET
12:25-12:35 GMTBREAK14:35 EET
12:35 GMTMukavaThe measurement of biopotential signals (such as ECG and EEG) is a widely employed method in health-care for illness diagnosis and patient state monitoring as well as in sport and wellbeing sectors to track performance, recovery, and physiological state of the body. The existing mainstream method to realize the electrical contact to skin is via disposable pregelled Ag/AgCl electrodes. Despite of market domination pregelled Ag/AgCl electrodes have many shortcomings such as skin irritation, wear discomfort, limited bandwidth and price point. VTT has invented and patented novel graphene based dry electrode solution which provides excellent signal quality and user comfort while being cheap and reliable in long-them measurements, thus eliminating all the pain points of hydrogel electrodes.

MedTech14:44 EET
12:44 GMTMedixmicroReplacing injections  – Creating value for healthcare chain with painless microneedle therapies.Presenter: Antti Rahikkala
Contact: antti.rahikkala@helsinki.fi
University: University of HelsinkiMedTech14:53 EET
12:53 GMTCorFlux – Digital twin analysis for improving the life expectancy of aortic aneurysm patientsThe diagnosis, treatment and monitoring of aortic aneurysms cause significant costs for worldwide healthcare systems and economies. CorFlux analysis is a completely new approach for assessing the criticality of aortic aneurysms. The analysis will enable healthcare professionals to make decisions related to the treatment of aortic aneurysm patients much more accurately than the current practice.Presenter: Tero Puustinen
Contact: tero.puustinen@uef.fi, matti.hoyto@uef.fi
University: University of Eastern FinlandMedTech / Health tech15:02 EET
13:02 GMTGlymphometerWearable device for monitoring glymphatic function in brain.Presenter: Teemu Myllylä
Contact: teemu.myllyla@oulu.fi
University: University of OuluMedTech / Diagnostics15:11 EET
13:11 GMTNosoreHow to estimate the risk for bed patient to get pressure ulcers. By measuring various physical parameters and using clever algorithm, the risk can be indicated and the nurses can take necessary actions.Presenter: Martti Vakkala
Contact: martti.vakkala@aalto.fi, nuno.nobre@aalto.fi
University: Aalto UniversityMedTech / Digital Health15:20 EET
13:20 GMTHentoTouchHow to treat alcoholism, especially how to prevent new “drinking lapses”. Idea is to right kind of generate haptic touch-based stimulus which will then cause the brain to produce dopamine (or similar).Presenter: Jukka Planman
Contact: jukka.planman@aalto.fi, julianna.harkki@aalto.fi, pauli.tuovinen@aalto.fi
University: Aalto UniversityMedTech / Digital Health / Diagnostics15:29 EET
13:29 GMTCLOSING WORDS & BREAK16:00 EET
14:00 GMTMATCHMAKING STARTS

Projects in the 2021 Finnish Health and Life Science Research Showcase

Read more about the 2021 event and feedback

Health Capital Helsinki